Abstract:Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a highly contagious and dangerous virus that caused the global COVID-19 pandemic in early 2020. It primarily affects the respiratory system, leading to severe illness and high rates of mortality worldwide. The virus enters the body by binding to a receptor called ACE2, which is present in specific cells of the lungs known as type 2 alveolar epithelial cells. Numerous studies have investigated the consequences of SARS-CoV-2 infection, revealing various impacts on the body. This review provides an overview of SARS-CoV-2, including its structure and how it infects cells. It also examines the different variants of concern, such as Alpha, Beta, Gamma, Delta, and the more recent Omicron variant, discussing their characteristics and the level of damage they cause. The usage of drugs to treat COVID-19 is another aspect that has been covered and compares the effectiveness and use of antiviral drugs in the treatment and its potential benefits in COVID-19 treatment. Furthermore, this review explores the consequences and abnormalities associated with SARS-CoV-2 infection, including its impact on various organs and systems in the body. And also discussing the different COVID-19 vaccines available and their effectiveness in preventing infection and reducing the severity of illness. The current review ensures the recent update of the COVID research with expert's knowledge, collection of numerous data from reliable sources and methodologies as well as update of findings based on reviews. This review also provided clear contextual explanations to aid the interpretation and application of the results. The main motto and limitation of this manuscript are to address the computational methods of drug discovery against the rapidly evolving SARS-CoV-2 virus, which has been discussed. Additionally, current computational approaches which are cost effective and can able to predict the therapeutic agents for the treatment against the virus have also been discussed.

COVID‐19: From pathogenesis models to the first drug trials

Mechanistic Models of COVID-19: Insights into Disease Progression, Vaccines, and Therapeutics

Animal and translational models of SARS-CoV-2 infection and COVID-19

Recent insights for the emerging COVID-19: drug discovery, therapeutic options and vaccine development

Editorial: Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response

The modelling of COVID19 pathways sheds light on mechanisms, opportunities and on controversial interpretations of medical treatments. v2

Therapeutic strategies for COVID-19: progress and lessons learned

Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2

Current state-of-the-art and potential future therapeutic drugs against COVID-19

COVID-19: Discovery, diagnostics and drug development

COVID-19 drug discovery and treatment options

Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19

A review on recent theoretical approaches made in the discovery of potential Covid-19 therapeutics

Stopping pandemics before they start: Lessons learned from SARS-CoV-2

Advances and gaps in SARS-CoV-2 infection models

COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses

Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development

An unprecedented global challenge, emerging trends and innovations in the fight against COVID-19: A comprehensive review

Coronavirus biology and replication: implications for SARS-CoV-2

Lessons learnt from broad-spectrum coronavirus antiviral drug discovery